|

Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes

RECRUITINGN/ASponsored by Indiana University
Actively Recruiting
PhaseN/A
SponsorIndiana University
Started2023-06-07
Est. completion2026-08-17
Eligibility
Age65 Years+
Healthy vol.Accepted
Locations1 site

Summary

Aim 1: Characterize shared decision-making and unmet patient-caregiver dyads needs for patients with diabetes and Alzheimer's Disease and related dementias (ADRD) while using a continuous glucose monitoring (CGM) device. Aim 2: Develop an interactive tool to enhance shared decision-making for diabetes management.

Eligibility

Age: 65 Years+Healthy volunteers accepted
Patient-Caregiver Dyad Inclusion Criteria (Aims 1 + 2):

* patient must have dual diagnosis of MCI or ADRD and diabetes (DM)
* patient must have active prescriptions for DM
* patient must have had at least one visit to an Eskenazi or IU Health primary care clinic within 12 months
* patient must be able to provide assent and have a legally authorized representative (LAR) consent on their behalf if patient lacks capacity to consent
* patient must have a caregiver aged 18 years or older who interacts daily, or almost daily, with the patient
* patient and caregiver must both speak English
* patient and caregiver must both reside in the community
* dyad must have internet access

Patient-Caregiver Dyad Exclusion Criteria (Aims 1 +2):

* patient has terminal illness
* use of an automated insulin delivery system
* patient is receiving dialysis
* patient is taking ascorbic acid during monitoring period
* patient has existing implanted medical devices
* patient has a bleeding disorder
* patient has a pre-existing arm skin lesions
* patient has an allergy to medical adhesive or isopropyl alcohol
* patient has plans for imaging or diathermy treatment during the study period

Clinician Participant Inclusion Criteria (Aim 2):

* primary care physicians
* nurses
* pharmacists
* nutritionists
* psychologists
* medical residents

Clinician Participant Exclusion Criteria (Aim 2):

* only treats patients younger than 65 years
* does not manage patients' DM

Conditions5

Alzheimer's DiseaseAlzheimer's Disease (Incl Subtypes)DementiaDiabetesHypoglycemia

Locations1 site

Eskenazi Health
Indianapolis, Indiana, 46202
Patricia Noblet

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.